Plus   Neg

Domino's Pizza Issues Outlook - Quick Facts

Domino's Pizza, Inc. (DPZ) announced a new two- to three-year outlook for certain business metrics. Global net unit growth is projected in a range of 6% - 8%. Global retail sales growth, excluding foreign currency impact, is expected to be in a range of 6% - 10%.

Fourth quarter EPS, as adjusted, was $3.46, up 10.5% over the prior year quarter. Total revenues increased to $1.36 billion from $1.15 billion, prior year. Global retail sales increased 21.7% in the fourth quarter, or 20.9% excluding the positive impact of foreign currency. Global retail sales rose 12.0%, excluding the positive impact of foreign currency and the impact of the 53rd week.

On February 24, the company's Board declared a quarterly dividend of $0.94 per common share payable on March 30, 2021 to shareholders of record at the close of business on March 15, 2021. This represents an increase of 20.5% over the previous quarterly dividend amount.

The company's Board authorized a new share repurchase program to repurchase up to $1.0 billion of the company's common stock. This repurchase program replaces the remaining availability of approximately $76.6 million under the previously approved $1.0 billion share repurchase program.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Intel Corp. (INTC) Thursday reported a profit and revenues for the first quarter that trumped Wall Street estimates, driven by continued demand for PCs. Moving ahead, the company lifted its full-year outlook. Santa Clara, California-based Intel reported first-quarter profit of $3.36 billion or $0.82... A third of those American adults now refusing to get vaccinated would get vaccinated if they could take a pill instead of getting the vaccine shot, according to a poll conducted by Quadrant Strategies and commissioned by biotechnology company Vaxart, Inc. A pill vaccine is expected to overcome vaccine resistance of millions of Americans. While reporting financial results for the first quarter on Thursday, Biogen Inc. (BIIB) raised its adjusted earnings guidance for the full-year 2021, but maintained revenue outlook. For fiscal 2021, the company raised its adjusted earnings guidance to a range of $17.50 to $19.00 per share from the...
Follow RTT